News
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
Health and Me on MSN3h
Scented Candles Are Harming Your Lungs—Here's HowScented candles have taken the market by storm. Known to be therapeutic, these candles are quickly making their way into our ...
We recently published a list of 12 Best Major Stocks to Buy According to Billionaires. In this article, we are going to take ...
Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. Barbara ...
Foreign investors sold South Korean stocks for the ninth straight month due to lingering worry about economic slump, ...
A blockbuster antitrust trial featuring Meta kicked off in the US last week, with CEO Mark Zuckerberg taking the stand in court to defend the tech giant’s acquisitions of Instagram and WhatsApp over a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback